Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRL
ZBH
Add up to 3 more stocks
CRL
Charles River Laboratories International, Inc.
+1.17%
$290.19+3.36Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$13.98B
52W Range
$146.20 - $303.31
ZBH
Zimmer Biomet Holdings, Inc.
+0.26%
$88.29+0.23Delayed quote: Oct 2, 2026, 4:02 PM EDT
Market Cap
$17.08B
52W Range
$79.12 - $106.88
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 21.48 |
| Forward P/E | 25.57 | 10.35 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 4.92 | 1.35 |
| P/S Ratio | 3.50 | 2.01 |
| P/FCF Ratio | 37.72 | N/A |
| EV/EBITDA | 21.24 | 10.33 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 32.2% | 61.6% |
| Operating Margin | 12.3% | 15.7% |
| Net Margin | -6.0% | 9.5% |
| ROE | -8.4% | 6.4% |
| ROA | -3.2% | 3.5% |
| ROIC | 7.7% | 5.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 1.69 |
| Quick Ratio | 1.04 | 1.69 |
| Debt/Equity | 1.07 | 0.59 |
| Interest Coverage | 4.74 | 4.65 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 1.1% |
| Payout Ratio | N/A | 23.4% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.